Crossmark

A Cu-based metal-organic framework based on desloratadine and siHIF-1α for achievement of genes/drugs/CDT combination therapy in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1186/s12951-026-04334-0

Published Online: 2026-04-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ding, Ding

Huang, Zhe

Wang, Lu

Wang, Ziwen

Qin, Juan

Ni, Man

Yao, Baiyu

Yang, Yanchao
License Information

Text and Data Mining valid from 2026-04-20

Version of Record valid from 2026-06-02
More Information

Article History

Received: 12 November 2025

Accepted: 21 March 2026

First Online: 20 April 2026

Declarations

:

: The animal experiments were sanctioned by the Experimental Animal Ethics Committee of Yangzhou University (No. 202408036).

: All authors agree to publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below